Diffuse large B-cell lymphoma.

Archives of Pathology & Laboratory Medicine
Kristin E Hunt, Kaaren K Reichard

Abstract

Diffuse large B-cell lymphoma is the most common lymphoma worldwide. Both morphologically and prognostically it represents a diverse spectrum of disease. Traditional morphologic subclassification often results in poor interobserver reproducibility and has not been particularly helpful in predicting outcome. Recent gene expression profiling studies have classified diffuse large B-cell lymphoma into 2 main subtypes, germinal center B-cell and activated B-cell, with the germinal center type showing an overall better survival. Validation of these subtypes has become possible for the practicing pathologist with the use of surrogate immunohistochemical markers. Importantly however, these prognostic studies were performed on material from the pre-rituximab treatment era. With the now well-accepted addition of rituximab (anti-CD20 antibody) to the typical large B-cell lymphoma chemotherapeutic regimen, a revalidation of any survival differences between the large B-cell lymphoma subgroups is necessary. This short review covers the current clinical, morphologic, immunophenotypic, genetic, gene expression profiling, and prognostic (studies before and after the addition of rituximab) features of de novo diffuse large B-cell lymphoma.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
May 15, 1998·European Journal of Haematology·A SalarA Grañena
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Apr 13, 2000·American Journal of Clinical Pathology·C C ChangS L Perkins
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Izidore S LossosRonald Levy
Aug 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·George WrightLouis M Staudt
Apr 30, 2004·The New England Journal of Medicine·Izidore S LossosRonald Levy
Aug 18, 2004·Current Opinion in Oncology·Randy D Gascoyne
Dec 4, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Francisco VegaJeffrey L Jorgensen
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FeugierB Coiffier
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Nov 11, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Neeraja KambhamYasodha Natkunam
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Izidore S Lossos, Daniel Morgensztern
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning

❮ Previous
Next ❯

Citations

Dec 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul N MeyerDennis D Weisenburger
Oct 4, 2016·Journal of Molecular Histology·Pumza MaganganeRichard Naidoo
Jun 20, 2020·International Journal of Surgical Pathology·Absalom MwazhaPedzisai Mazengenya
Jun 23, 2020·Journal of Endodontics·Joseph A ShilkofskiNader K Salib
Jun 25, 2020·International Journal of Molecular Sciences·Soo Jin KimKeon Wook Kang
Nov 1, 2016·Current Opinion in Urology·Barrett McCormickPhilippe E Spiess
Sep 12, 2014·Journal of the Royal Society, Interface·Luz Adriana Nicasio-CollazoEnrique Hernández-Lemus
Nov 26, 2009·Journal of Gastrointestinal Cancer·Nikolaos S SalemisVasilios Karathanasis
Aug 12, 2021·The British Journal of Radiology·Eric D BrooksChelsea C Pinnix
Mar 12, 2008·Medical Microbiology and Immunology·Ari WaismanFiliz Demircik
Jun 25, 2008·British Journal of Haematology·Graham Packham
Jul 12, 2008·Cancer Genetics and Cytogenetics·L Goldberg-BittmanA Amiel
Oct 22, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Gian Cesare Guidi, Giuseppe Lippi
Nov 15, 2008·International Journal of Dermatology·Anne-Moon van Tuyll van SerooskerkenAriënne M W van Marion
Jul 7, 2009·Hematology/oncology Clinics of North America·Qian-Yun Zhang, Kathryn Foucar
May 4, 2010·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Min-Shu HsiehChung-Wu Lin
Dec 22, 2010·American Journal of Clinical Pathology·Paul N MeyerDennis D Weisenburger
Jan 12, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Marzia OgnibeneAlessandra Eva
Mar 30, 2011·Clinical Journal of Oncology Nursing·Gretchen A McNally
May 12, 2011·Applied Immunohistochemistry & Molecular Morphology : AIMM·Asmaa Gaber AbdouMarwa Salah Gad Allah
Jan 1, 2011·Medical Journal, Armed Forces India·Kavita SahaiN S Mani

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.